Track the Chimeric Therapeutics Limited share price and the full management transaction log of the company, a publicly traded company based in Australia. Shares are listed on AU AU, under the oversight of ASX. Operating in the Health Care sector, Chimeric Therapeutics Limited has published 1 insider filings. Market capitalisation: €3.6m. The latest transaction was disclosed on 5 May 2026 (Change in Substantial Holding). Among the most active insiders: GKCC LLC. Every trade is free.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.